Aflibercept for diabetic macular edema

被引：0
|
作者：
Udaondo, Patricia [1 ]
Garcia-Delpech, Salvador [1 ]
Matinez-Costa, Rafael [1 ]
Navarro-Piera, Juan [2 ]
Cisneros-Lanuza, Angel [1 ]
机构：
[1] La Fe Univ & Polytech Hosp, Valencia, Spain
[2] Francesc Borja Hosp, Gandia, Spain
来源：
EXPERT REVIEW OF OPHTHALMOLOGY | 2014年 / 9卷 / 04期
关键词：
aflibercept; anti-VEGF; avastin; intravitreal injection; laser; macula; macular degeneration; macular edema; anibizumab; retina;
D O I：
10.1586/17469899.2014.931809
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
Different intravitreal anti-VEGF medications have been used for the management of retinal vascular disorders with highly satisfactory results and good safety profiles. Aflibercept, a new anti-VEGF drug with a different mechanism of action compared with prior therapies, has recently emerged. The results of aflibercept Phase II and III studies show its efficacy for the treatment of wet age-related macular degeneration, macular edema secondary to central retinal vein occlusion and diabetic macular edema.
引用
收藏
页码：263 / 268
页数：6
相关论文
共 50 条
  • [21] Aflibercept therapy for diabetic macular edema resistant to ranibizumab and bevacizumab
    Karth, Peter
    Moshfeghi, Darius M.
    Leng, Theodore
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (13)
  • [22] Efficacy of Ranibizumab Therapy with Aflibercept in Patients with Diabetic Macular Edema
    Teixeira, Leonardo Pinheiro
    Dalia, Eduardo
    Campos, Luana
    Abrahao, Mayara Martins
    Nassaralla, Joao J.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2016, 57 (12)
  • [23] AFLIBERCEPT AND NAVIGATED VERSUS CONVENTIONAL LASER IN DIABETIC MACULAR EDEMA
    Blindbaek, S.
    Peto, T.
    Grauslund, J.
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2019, 29 (03) : NP28 - NP29
  • [24] Aflibercept with adjuvant micropulsed yellow laser versus aflibercept monotherapy in diabetic macular edema
    Khattab, Abeer M.
    Hagras, Sherein M.
    AbdElhamid, AhmedHosni
    Torky, Magda A.
    Awad, Eman A.
    Abdelhameed, Ameera G.
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2019, 257 (07) : 1373 - 1380
  • [25] Aflibercept with adjuvant micropulsed yellow laser versus aflibercept monotherapy in diabetic macular edema
    Abeer M. Khattab
    Sherein M. Hagras
    AhmedHosni AbdElhamid
    Magda A. Torky
    Eman A. Awad
    Ameera G. Abdelhameed
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2019, 257 : 1373 - 1380
  • [26] Intravitreal Aflibercept for the Treatment of Diabetic Macular Edema: Evaluating the Impact on Diabetic Retinopathy
    Mitchell, Paul
    Gillies, Mark C.
    Larsen, Michael
    Staurenghi, Giovanni
    Holz, Frank G.
    Katz, Todd A.
    Lu, Chengxing
    Ahlers, Christiane
    Metzig, Carola
    Zeitz, Oliver
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2015, 56 (07)
  • [27] Comparison of aflibercept and ranibizumab in diabetic macular edema associated with subretinal detachment
    Ozkaya, Abdullah
    Demir, Gokhan
    Kirmaci, Asli
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2020, 30 (02) : 363 - 369
  • [28] Changes in metamorphopsia following intravitreal aflibercept injection for diabetic macular edema
    Tomoya Murakami
    Fumiki Okamoto
    Yoshimi Sugiura
    Shohei Morikawa
    Yoshifumi Okamoto
    Takahiro Hiraoka
    Tetsuro Oshika
    Scientific Reports, 12
  • [29] Safety and Outcomes of Intravitreal Aflibercept in Diabetic Macular Edema - A Systematic Review
    Dascalu, Ana Maria
    Rizzo, Manfredi
    Rizvi, Ali A.
    Stoian, Anca Pantea
    Iancu, Raluca Claudia
    Stana, Daniela
    Tudosie, Mihail Silviu
    Serban, Dragos
    CURRENT PHARMACEUTICAL DESIGN, 2022, 28 (21) : 1758 - 1768
  • [30] Comparisons of Efficacy of Intravitreal Aflibercept and Ranibizumab in Eyes with Diabetic Macular Edema
    Shimizu, Norihiro
    Oshitari, Toshiyuki
    Tatsumi, Tomoaki
    Takatsuna, Yoko
    Arai, Miyuki
    Sato, Eiju
    Baba, Takayuki
    Yamamoto, Shuichi
    BIOMED RESEARCH INTERNATIONAL, 2017, 2017
12345